BRIEF published on 07/09/2026 at 10:05, 4 days 15 hours ago Axxam and HeartBeat.bio Form Partnership for Cardiovascular Drug Innovation New Approach Methodologies Cardiovascular Drug Discovery Cardiac Safety Assessment Human Cardiac Organoids Drug Discovery Collaboration
BRIEF published on 07/09/2026 at 10:05, 4 days 15 hours ago Axxam et HeartBeat.bio s'associent pour l'innovation dans le domaine des médicaments cardiovasculaires Nouvelles Méthodologies D'approche Découverte De Médicaments Cardiovasculaires Évaluation De La Sécurité Cardiaque Organoïdes Cardiaques Humains Collaboration En Matière De Découverte De Médicaments
PRESS RELEASE published on 07/09/2026 at 10:00, 4 days 15 hours ago Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment Axxam and HeartBeat.bio form strategic partnership to enhance cardiovascular drug discovery and safety assessment with human cardiac organoid technology Partnership Axxam HeartBeat.bio Cardiovascular Drug Discovery Human Cardiac Organoid
BRIEF published on 09/23/2025 at 10:05, 9 months 20 days ago HeartBeat.bio Collaborates with Boehringer Ingelheim on Gene Therapies Cardiovascular Health Research Collaboration Gene Therapies Heart Muscle Disorders Cardioid Platform
BRIEF published on 09/23/2025 at 10:05, 9 months 20 days ago HeartBeat.bio collabore avec Boehringer Ingelheim sur les thérapies géniques Santé Cardiovasculaire Collaboration En Recherche Thérapies Géniques Troubles Du Muscle Cardiaque Plateforme Cardioïde
PRESS RELEASE published on 09/23/2025 at 10:00, 9 months 20 days ago HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders HeartBeat.bio collaborates with Boehringer Ingelheim to develop gene therapies for genetic cardiomyopathies, addressing unmet needs in heart health Heart Health Gene Therapy Boehringer Ingelheim HeartBeat.bio Cardiomyopathies
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 8 months ago HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
Published on 07/14/2026 at 01:45, 14 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 1 hour 58 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 2 hours 49 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 4 hours 24 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 5 hours 59 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/13/2026 at 22:30, 3 hours 28 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 4 hours 38 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 4 hours 41 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 5 hours 10 minutes ago EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 5 hours 36 minutes ago EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 7 hours 59 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
